This guideline describes the procedure which must be followed whenever a diagnosis of Mycobacterium Tuberculosis (M.TB) infection is suspected or confirmed, to optimally protect staff, patients and other visitors from risk of infection and assist in the care of the child with M.TB (not including Occupational Health policy).
The Dubowitz Neuromuscular Centre (DNC) at Great Ormond Street Hospital (GOSH) is a leading clinical and research centre specialising in neuromuscular disorders affecting children. The DNC provides clinical assessment, diagnostic services and advice on treatment and rehabilitation.
This clinical guideline from Great Ormond Street Hospital (GOSH) discusses nutritional requirements for preterm infants receiving enteral nutrition. It does not give guidance on the prescription of parenteral nutrition (PN).
The purpose of this guideline is to provide guidance about mouth care at Great Ormond Street Hospital (GOSH).
NOTE: We review our guidelines regularly and this guideline is now past its review date. The content of the guideline below may not reflect the most recent evidence based practice. Please use with caution.
This guideline is intended to guide and facilitate the care of patients under the care of the clinical teams at Great Ormond Street Hospital for Children NHS Trust (GOSH). It has been approved by the Guideline Approval Group and is for use by staff of all disciplines and levels in these health care teams. The guidance contained here in is not intended to replace individual assessment and personalised treatment of the patient.
This information from Great Ormond Street Hospital (GOSH) explains severe combined immunodeficiency or SCID. SCID is the name given to a group of rare inherited disorders which cause severe abnormalities of the immune system.
Landau Kleffner syndrome (LKS) is a rare epilepsy. It occurs in children usually between the ages of three and nine years and is characterised by loss of language skills and silent electrical seizures during sleep. It may be associated with convulsive seizures and additional difficulties with behaviour, social interaction, motor skills and learning. It is not usually life-threatening, but can impact greatly on quality of life unless it responds well to treatment. It occurs in approximately one child in a million. The disease is more common in boys and does not usually run in families.